Member Press Releases

10Jun 2020

Read the full press release from Catalent here. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Spicona, Inc. to develop a virus-like protein (VLP)-based vaccine against COVID-19. Under the terms […]

09Jun 2020

Read the full press release from Illumina here. Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. […]

03Jun 2020

Read the full press release from Eurofins here. Eurofins Technologies announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19. The development of the assay has been led by Eurofins Ingenasa, a Eurofins Technologies company involved in the development of diagnostic tests […]

02Jun 2020

Read the full press release from the Wisconsin Alumni Research Foundation here. $100K fund to accelerate solutions being developed by UW–Madison researchers MADISON, Wis. – The Wisconsin Alumni Research Foundation announced that nine highly deployable projects have been selected to receive development funding through the UW/WARF COVID-19 Accelerator Challenge. From improved respirators to accelerated testing, […]

26May 2020

Read the full press release from Merck here. Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are: Merck […]

11May 2020

Read the full press release from SHINE Medical Technologies here. SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it […]

11May 2020

Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company’s commercial […]

15Apr 2020

Read the full press release from DuPont here. The #TyvekTogether Program will introduce a new specialized Tyvek®  fabric to enable an increase in the amount of garment production for the COVID-19 response to 15 million garments a month. Download PDF here WILMINGTON, Del., April 15, 2020 – DuPont (NYSE:DD) today launched a new program,  #TyvekTogether, to increase the overall availability of Tyvek® personal […]

09Apr 2020

Read the full press release here. Viracor Eurofins received FDA EUA for its RT-PCR SARS-CoV-2 Virus LDT. Eurofins Genomics expands capacity for probes and primers production for RT-PCR SARS-CoV-2 test kits Eurofins Technologies, a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods, announces the launch of a range […]